Monogram Orthopaedics, Inc. () Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

Shareholding (Jun 2025)

FII

0.07%

Held by 4 FIIs

DII

96.35%

Held by 4 DIIs

Promoter

0.00%

How big is Monogram Orthopaedics, Inc.?

22-Jun-2025

As of Jun 18, Monogram Orthopaedics, Inc. has a market capitalization of 98.82 million, with net sales of 0.00 million and a net profit of -16.01 million over the latest four quarters. The company reported shareholder's funds of 14.50 million and total assets of 17.77 million as of Dec 24.

What does Monogram Orthopaedics, Inc. do?

22-Jun-2025

Monogram Orthopaedics, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $3 million and a market cap of $98.82 million. Key financial metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -136.96%.

Is Monogram Orthopaedics, Inc. technically bullish or bearish?

20-Sep-2025

As of September 8, 2025, Monogram Orthopaedics, Inc. shows a bullish trend with strong momentum, despite a bearish weekly RSI indicating short-term weakness, and has significantly outperformed the S&P 500 year-to-date.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 234 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-1.47

Return on Equity

-207.89%

Price to Book

27.11

Revenue and Profits:

Net Sales:

(Quarterly Results - Jun 2025)

Net Profit:

-5 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

81.82%

6 Months

151.05%

1 Year

158.62%

2 Years

120.59%

3 Years

1491.51%

4 Years

1491.51%

5 Years

1491.51%

Monogram Orthopaedics, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Is Monogram Orthopaedics, Inc. technically bullish or bearish?

As of 8 September 2025, the technical trend for Monogram Orthopaedics, Inc. has changed from mildly bullish to bullish. The current stance is bullish with a strong momentum indicated by the weekly and monthly MACD being bullish. The daily moving averages also confirm this bullish trend. However, the weekly RSI is bearish, suggesting some short-term weakness. The Bollinger Bands are bullish on the weekly and mildly bullish on the monthly, indicating potential upward price movement. In terms of performance, Monogram has significantly outperformed the S&P 500 across multiple periods, with a year-to-date return of 143.46% compared to the S&P 500's 12.22%. Overall, the technical indicators suggest a bullish outlook, albeit with some caution due to the bearish weekly RSI....

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

6.30%

EBIT Growth (5y)

-248.05%

EBIT to Interest (avg)

-16.50

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.12

Sales to Capital Employed (avg)

0.03

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

6.04%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

7.46

EV to EBIT

-4.92

EV to EBITDA

-5.07

EV to Capital Employed

-51.41

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-136.96%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

Bearish

No Signal

Bollinger Bands

Mildly Bullish

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Mildly Bearish

Dow Theory

No Trend

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Jun 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 3 Schemes (3.57%)

Foreign Institutions

Held by 4 Foreign Institutions (0.07%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -54.29% vs 32.69% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.90",
          "val2": "-3.50",
          "chgp": "17.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-5.40",
          "val2": "-3.50",
          "chgp": "-54.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -100.00% vs 0.00% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -18.98% vs 0.00% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.40",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-14.90",
          "val2": "-16.90",
          "chgp": "11.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "3.10",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-16.30",
          "val2": "-13.70",
          "chgp": "-18.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "-47,309.80%",
          "chgp": "4,730.98%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-2.90

-3.50

17.14%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-5.40

-3.50

-54.29%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -54.29% vs 32.69% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

0.00

0.40

-100.00%

Operating Profit (PBDIT) excl Other Income

-14.90

-16.90

11.83%

Interest

0.00

Exceptional Items

0.00

3.10

-100.00%

Consolidate Net Profit

-16.30

-13.70

-18.98%

Operating Profit Margin (Excl OI)

0.00%

-47,309.80%

4,730.98%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -100.00% vs 0.00% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -18.98% vs 0.00% in Dec 2023

All Annual Results

Company CV

About Monogram Orthopaedics, Inc.

Monogram Orthopaedics, Inc.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

Monogram Orthopaedics, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is Monogram Orthopaedics, Inc.?

Watch in Real-Time

What does Monogram Orthopaedics, Inc. do?

Is Monogram Orthopaedics, Inc. technically bullish or bearish?

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Is Monogram Orthopaedics, Inc. technically bullish or bearish?

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Jun 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Annual Results Snapshot (Consolidated) - Dec'24

About Monogram Orthopaedics, Inc.

Company Coordinates